CytomX Therapeutics
CTMX
#9040
Rank
HK$0.66 B
Marketcap
HK$8.47
Share price
0.00%
Change (1 day)
-26.75%
Change (1 year)

EPS for CytomX Therapeutics (CTMX)

EPS in 2023 (TTM): -HK$6.58

According to CytomX Therapeutics 's latest financial reports the company's current EPS (TTM) is -HK$6.52. In 2022 the company made an earnings per share (EPS) of -HK$13.28 an increase over its 2021 EPS that were of -HK$14.14.

EPS history for CytomX Therapeutics from 2015 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$6.58-50.47%
2022-HK$13.28-6.04%
2021-HK$14.1430.94%
2020-HK$10.80-52.56%
2019-HK$22.7645.05%
2018-HK$15.6972.65%
2017-HK$9.09-27.78%
2016-HK$12.5835.65%
2015-HK$9.28

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-HK$16.93 159.52%๐Ÿ‡บ๐Ÿ‡ธ USA